By Priyanjana Pramanik, MSc. A small but rigorous randomized trial suggests paracetamol may be a feasible alternative to ibuprofen for late PDA treatment, while underscoring the need for larger ...

The FDA believes that data on MRD and complete response can expedite new drug delivery compared with long-term survival ...

Dutch trial establishes feasibility of screening approach in routine specialty care ...

January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences ...

The FDA released a draft guidance document that provides a regulatory framework for sponsors to utilize minimal residual ...

In patients with high-risk melanoma, the personalized cancer vaccine intismeran autogene and Keytruda reduced the risk of ...

The Institute for the Advancement of Food & Nutrition Science publishes a list of general principles it hopes will inform any ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

FDA has designated rexlemestrocel-L a Regenerative Medicine Advanced Therapy (RMAT) for the treatment of chronic low back pain. RMAT designation provides all the benefits of Breakthrough and Fast ...

Study Shows Your Approach to Hobbies Matters More Than the Hobby Itself In A Nutshell Age matters for emotional benefits: A 5 ...

Marathon is making a major change compared to other extraction shooters and it could be the game's deciding factor on success ...

People Science, a leader in decentralized clinical research, today announced the publication of a clinical study conducted with Verb Biotics in Nature Scientific Reports. The peer-reviewed trial ...